Caregivers' Willingness to Accept Expedited Vaccine Research During the COVID-19 Pandemic: A Cross-sectional Survey

This study determined the predictors of caregivers' willingness to accept an accelerated regulatory process for the development of vaccines against coronavirus disease 2019 (COVID-19). An international cross-sectional survey was administered to 2557 caregivers of children in 17 pediatric emerge...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical therapeutics 2020-11, Vol.42 (11), p.2124-2133
Hauptverfasser: Goldman, Ran D., Marneni, Shashidhar R., Seiler, Michelle, Brown, Julie C., Klein, Eileen J., Cotanda, Cristina Parra, Gelernter, Renana, Yan, Tyler D., Hoeffe, Julia, Davis, Adrienne L., Griffiths, Mark A., Hall, Jeanine E., Gualco, Gianluca, Mater, Ahmed, Manzano, Sergio, Thompson, Graham C., Ahmed, Sara, Ali, Samina, Shimizu, Naoki
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:This study determined the predictors of caregivers' willingness to accept an accelerated regulatory process for the development of vaccines against coronavirus disease 2019 (COVID-19). An international cross-sectional survey was administered to 2557 caregivers of children in 17 pediatric emergency departments (EDs) across 6 countries from March 26, 2020, to June 30, 2020. Caregivers were asked to select 1 of 4 choices with which they most agreed regarding a proposed COVID-19 vaccine–approval process, in addition to questions regarding demographic characteristics, the ED visit, and attitudes about COVID-19. Univariate analyses were conducted using the Mann–Whitney U test for comparing non–normally distributed continuous variables, an independent t test for comparing normally distributed continuous variables, and a χ2 or Fisher exact test for categorical variables. Multivariate logistic regression analysis was used for determining independent factors associated with caregivers' willingness to accept abridged development of a COVID-19 vaccine. A P value of
ISSN:0149-2918
1879-114X
DOI:10.1016/j.clinthera.2020.09.012